Author

Tricia Finney-Hayward 1

1 AbbVie, Maidenhead

A STRUCTURED PAEDIATRIC TO ADULT TRANSITION SERVICE IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE REDUCES DISEASE FLARES, REQUIREMENT FOR STEROIDS AND EMERGENCY ADMISSIONS: THE TRANSIT STUDY

Sara McCartney, James Lindsay, Richard K Russell, Daniel R. Gaya, Ian Shaw, Tricia Finney-Hayward, Shaji Sebastian

EFFICACY AND SAFETY OF ADALIMUMAB IN PEDIATRIC PATIENTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS OF A RANDOMIZED-CONTROLLED PHASE 3 STUDY

Nicholas M. Croft, William A Faubion, Subra Kugathasan, Jaroslaw Kierkuś, Frank Ruemmele, Nael M. Mostafa, Mary Venetucci, Tricia Finney-Hayward, Mareike Bereswill, Andreas Lazar, Dan Turner

PATIENT-REPORTED BURDEN OF CORTICOSTEROID USE IN INFLAMMATORY BOWEL DISEASE IN THE UK: RESULTS FROM THE DETERMINANTS, INCIDENCE AND CONSEQUENCES OF CORTICOSTEROID EXCESS (DICE) IMPACT QUESTIONNAIRE

Eman Al Sulais, Gareth Parkes, Krisztina B. Gecse, Tricia Finney-Hayward, Christian P. Selinger, Tim Raine

PATTERNS OF CORTICOSTEROID EXPOSURE AND EXCESS IN INFLAMMATORY BOWEL DISEASE: RESULTS FROM THE DETERMINANTS, INCIDENCE AND CONSEQUENCES OF CORTICOSTEROID EXCESS (DICE) ONLINE MONITORING TOOL

John Wye, Edouard Louis, Stephane NANCEY, Irina Blumenstein, Revital Barkan, Walter Fries, Fernando Gomollón, Aykut Ferhat Çelik, Christian P. Selinger, Gareth Parkes, Tricia Finney-Hayward, Tim Raine

RAPIDITY OF SYMPTOM CONTROL WITH UPADACITINIB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM TWO RANDOMIZED PHASE 3 STUDIES

Edward V. Loftus, Ken Takeuchi, Xiang Gao, Remo Panaccione, Dapo Ilo, Tricia Finney-Hayward, Wen Zhou, Silvio Danese, Charles Phillips, Xuan Yao, Severine Vermeire

Item 1 - 5 / 5
1